rs753390261
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PM5PP3_ModeratePP5
The NM_024301.5(FKRP):āc.544T>Cā(p.Tyr182His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000646 in 1,547,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y182S) has been classified as Uncertain significance.
Frequency
Consequence
NM_024301.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FKRP | NM_024301.5 | c.544T>C | p.Tyr182His | missense_variant | 4/4 | ENST00000318584.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FKRP | ENST00000318584.10 | c.544T>C | p.Tyr182His | missense_variant | 4/4 | 1 | NM_024301.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151758Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000137 AC: 2AN: 145818Hom.: 0 AF XY: 0.0000247 AC XY: 2AN XY: 80862
GnomAD4 exome AF: 0.00000573 AC: 8AN: 1395518Hom.: 0 Cov.: 32 AF XY: 0.00000434 AC XY: 3AN XY: 690506
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151758Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74100
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2021 | The p.Y182H variant (also known as c.544T>C), located in coding exon 1 of the FKRP gene, results from a T to C substitution at nucleotide position 544. The tyrosine at codon 182 is replaced by histidine, an amino acid with similar properties. This variant has been identified in patients with limb-girdle muscular dystrophy (LGMD) in both the homozygous and compound heterozygous states (Sframeli M et al. Neuromuscul Disord, 2017 Sep;27:793-803; Johnson K et al. Skelet Muscle, 2018 07;8:23). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Walker-Warburg congenital muscular dystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 25, 2023 | This sequence change replaces tyrosine, which is neutral and polar, with histidine, which is basic and polar, at codon 182 of the FKRP protein (p.Tyr182His). This variant is present in population databases (rs753390261, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of limb-girdle muscular dystrophy (PMID: 28688748, 30060766). ClinVar contains an entry for this variant (Variation ID: 285433). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FKRP protein function. This variant disrupts the p.Tyr182Cys amino acid residue in FKRP. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 14647208, 27439679, 28931339, 30003095). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Autosomal recessive limb-girdle muscular dystrophy type 2I Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Apr 06, 2018 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 04, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at